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ABSTRACT
Objectives: This study aimed to investigate whether there was a correlation between the expression of GATA binding 
protein 3 (GATA-3) and the proliferation of endometrium cells from women with endometriosis. 
Material and methods: Endometrial tissue was collected from 20 women with endometriosis (experimental group) 
and 10 women without endometriosis (control group). The primary endometrial cells were then cultured and identified. 
Each group of cells were further divided into four groups. The control group was divided into control-no treatment (C-N), 
control-negative control (C-NC, transfected with a scrambled siRNA negative control), control-lentiviral transfection control 
(C-LC) and control-GATA-3 lentiviral transfection (C-G3); the experimental group was divided into experiment-no treatment 
(E-N), experiment-negative control (E-NC), experiment-lentiviral transfection control (E-LC) and experiment-siGATA-3 lentiviral 
transfection (E-siG3). RT-PCR and western blot were used respectively to detect the endometrium cells’ GATA-3 mRNA and 
protein expression. Further, Cell Counting Kit-8 was used to measure the endometrium cells’ proliferation. 
Results: The relative expression of GATA-3 mRNA and protein in the E-N group was significantly higher than in the D-N 
group and E-siG3 group (P < 0.05). The relative cell proliferation rate in the C-G3 group at 48 h, 72 h and 96 h was signifi-
cantly higher than in the C-N, C-NC and C-LC groups (P < 0.05), while in the experimental group, the proliferation rate of 
the E-siG3 group was significantly lower than in the E-N, E-NC and E-LC groups (P < 0.05). 
Conclusions: This study suggests the role of GATA-3 in promoting proliferation of endometrial cells; therefore, GATA-3 may 
play an essential role in the development of endometriosis.
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INTRODUCTION
Endometriosis, characterized by endometrial-like tis-
sue and stroma outside the endometrial cavity, is known 
as a commonly encountered disease affecting 5–15% of 
women in their reproductive age [1]. Although 20–25% of 
women with endometriosis have no symptoms, patients 
may present with chronic pelvic pain, dysmenorrhea and 
infertility [2]. It has been nearly 90 years since this disease 
was initially described by Sampson [3], and several theo-
ries have been proposed to understand and explain the 
development of endometriosis [4]; however, the current 
understanding of the exact pathophysiology of endome-
triosis remains unclear.
Endometrial epithelial cells have been found by many 
recent studies working as a big source of cytokine produc-
tion, which plays a very important role in the immune, men-
strual and reproductive functions of endometrium [5, 6]. 
For instance, one study suggested that the imbalance of 
T helper type 1 and 2 (Th1/Th2) cytokines are of great im-
portance in the development of endometriosis [7]. Inter-
estingly, in lymphocytes, GATA binding protein 3 (GATA-3) 
has been proved to work as one of the most important 
cytokine expression regulators [8]. GATA-3, as a factor of 
the specific transcription of Th2 cell has its binding sites 
all cover the promoter regions of Th2 cytokines [9]. Impor-
tantly, it has been found that during the menstrual cycle, 
GATA-3 is expressed cyclically in the human endometrial 
epithelium [8]. Additionally, Peng et al. [10] suggested that 
the expression of GATA-3 in endometrial epithelial cells of 
women with endometriosis was higher than that of healthy 
women. Specially, it has been proposed that number of 
proliferating endothelial cells increase in the endometrium 
of endometriosis patients [11, 12], which implies that the 
proliferation of endometrial cells is important in the patho-
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genesis of endometriosis. However, to our knowledge, the 
role of GATA-3 in the proliferation of endometrial cells has 
not been investigated.
Objectives
In this study, endometrial tissue was collected from 
20 women with endometriosis and 10 women without en-
dometriosis, and the expression of GATA-3 in the endome-
trium cells of endometriosis patients and normal controls 
was compared. Further, the proliferation of endometrium 
cells from endometriosis patients and normal controls was 
investigated as well. This study may help to provide a deeper 
understanding on the mechanisms of GATA-3 that is in-
volved in the proliferation of endometrial cells.
MATERIALS AND METHODS
Sample collection
A total of 20 patients (aged 37–49) with late stage endo-
metriosis (experimental group) and 10 patients (aged 37–49) 
with carcinoma in situ of the cervix without endometriosis 
(control group) were included. At least six months prior to 
surgery, no patients received any gonadotropin-releasing 
hormone (GnRH) nor other hormone or anti-inflammatory 
medication. The endometrial tissues of all patients were ob-
tained through excision or curettage at Shengjing Hospital 
affiliated toChina Medical University.
The informed consent was signed by all patients or 
their first-degree relative before operation. Additionally, this 
study was approved by the Ethics Committee of Shengjing 
Hospital affiliated to China Medical University and was per-
formed in accordance with the ethical standards. All patients 
or their first-degree relatives signed an informed consent 
form prior to operation. Besides, the study was approved 
by the Ethics Committee of Shengjing Hospital affiliated to 
China Medical University, and it was carried out based on 
the ethical standards.
Primary endometrial cell culture 
and identification
The endometrial tissue samples from all groups were cut 
into pieces and digested with 0.1% type I collagen enzyme 
for 1 h at 37ºC. The cell suspension was passed through 
an 80 mesh sieve, then centrifuged at 850 rpm for 5 min. 
After removing the supernatant, Dulbecco Modified Eagle 
Medium (DMEM)/F-12 was added to resuspend cells. Then 
cell suspension was centrifuged again at 800 rpm for 10 min 
to remove neutrophils and erythrocytes. After that, cells 
were gently resuspended in DMEM/F-12 supplemented 
with 10% fetal bovine serum (FBS), and cell suspensions 
were cultured in flasks at 37ºC with 5% CO2. The endometrial 
cells were identified by immunocytochemical staining of 
keratin and vimentin. 
Groups
The primary endometrial cells of the experimental and 
control groups were divided into four groups: the control 
group into control-no treatment (C-N), control-negative 
control (C-NC, transfected with negative control scram-
bled siRNA), control-lentiviral transfection control (C-LC) 
and control-GATA-3 lentiviral transfection (C-G3); the ex-
perimental group into experiment-no treatment (E-N), 
experiment-negative control (E-NC), experiment-lentiviral 
transfection control (E-LC) and experiment-siGATA-3 lenti-
viral transfection (E-siG3). 
Lentiviral transfection
The GATA-3 RNA interference (RNAi) lentiviral vector, 
GATA-3 lentiviral vector, complementary DNA (cDNA) se-
quent synthesis, and scrambled siRNA negative control 
were constructed by Shanghai GeneChem Co., Ltd (Shang-
hai, China). Lentiviral transfection was conducted using 
a lentiviral vector particle kit purchased from Shanghai 
GeneChem Co., Ltd (Shanghai, China). The target sequence 
of siGATA-3 was 5’-AACAUCGACGGUCAAGGCAAC-3’ and of 
the scrambled control was 5’-TTCTCCGAACTGTCACGT-3’. 
In detail, cells were incubated with the recombinant len-
tivirus at the optimal multiplicity of infection (MOI) in se-
rum-free DMEM/F-12 containing 5 mg/mL polybrene at 
37ºC and 5% CO2. The media was changed after 15 h of 
transfection. The transfection efficiency was examined by 
fluorescence microscopy and flow cytometry after 48 h, and 
then was confirmed by real-time quantitative polymerase 
chain reaction (RT-PCR) and western blot.
RT-PCR
Total mRNA was isolated from cells using Trizol Reagent 
(Takara, Otsu, Shiga, Japan). First-strand cDNA was synthe-
sized using the PrimeScript First Strand cDNA Synthesis 
Kit. The SYBR PrimeScript RT-PCR Kit (Takara, Otsu, Shiga, 
Japan) was used for quantitative PCR with glyceralde-
hyde-3-phosphatedehydrogenase (GAPDH) as an internal 
control gene. In this assay the specific primers used were: 
GATA-3 sense, 5’-CGAGATGGCACGGGACACTA-3’, GATA-3 re-
verse, 5’-TGGTCTGACAGTTCGCACAGG-3’; GAPDH sense, 
5’-GCAC CGTCAAGGCTGAGAAC-3’, GAPDH reverse, 5’-ATG-
GTGGTGAAGACGCCAGT-3’. All reactions were performed 
in the LightCycler 2.0 System (50ºC for 2 min; 95ºC for 
10 min; 45 cycles of 95ºC for 15 s and 60ºC for 1 min). 
The GATA-3 relative expression value was calculated using 
the 2-ΔΔCT method [12]. 
Western blot 
Total protein was collected from the cells of the eight 
groups using a protein extraction kit (Keygen Biotechnology, 
Nanjing, China). About 50 μg of protein was separated by 
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10% sodium dodecyl sulfate-polyacrylamide gel electropho-
resis, and then transferred electrically onto a polyvinylidene 
fluoride membrane. After being blocked in 5% non-fat dried 
milk for 2 h, the membranes were incubated overnight with 
primary antibodies against either anti-mouse GATA-3 or 
GAPDH (1:500). Then, the membrane was incubated with 
horseradish peroxidase-conjugated goat anti-mouse IgG 
secondary antibody for 4 h. After washing, the signals were 
developed using an enhanced chemiluminescence kit. 
To quantify the target protein band intensities (gray-scale 
values) using Quantity One 1-D Analysis Software.
Cell proliferation assay
To detect the proliferation of cells, Cell Counting 
Kit-8 (CCK-8) (Dojindo Laboratories, Kunamoto, Japan) was 
used following the manufacturer’s instructions. Briefly, cell 
suspension (100 µL/well) was cultured in 96-well culture 
plates at 5.000 cells/well. After 15 h of lentiviral transfec-
tion, the medium was changed and cells were cultured for 
another 48, 72 or 96 h. Then in each well of the plate, 10 µl 
of the CCK-8 solution was added. After the incubation at 
37ºC with 5% CO2 for 4 h, the absorbance of each well was 
measured at 570 nm.
Statistical analysis
Data were shown as mean ± standard error (SE). SPSS 
software version 19.0 was applied to perform all statistical 
analyses (SPSS Corpoartion, Chicago, IL, USA). Dunnett’s 
t-test and one-way analysis of variance with Student-New-
man-Keul analysis were used for statistical comparison. 
A P < 0.05 was considered to be statistically significant.
RESULTS 
Relative expression of GATA-3 mRNA
As shown in Table 1 and Figure 1A, the relative expres-
sion of GATA-3 mRNA in the E-N group was 2.30 ± 0.03, 
which was significantly higher than in the D-N (1.00 ± 0.10) 
and E-siG3 group (0.62 ± 0.20) (P < 0.05). In control groups, 
the relative expression of GATA-3 mRNA in the C-G3 group 
(4.64 ± 0.14) was statistically higher than that in the C-N 
group (P < 0.05). No statistically difference was found be-
tween the C-NC and C-LC groups or between the E-NC and 
E-LC groups. 
Relative expression of GATA-3 protein
The relative expression of GATA-3 protein was shown in 
Table 1 and Figure 1B and 1C. When comparing the E-N group 
(2.43 ± 0.12) with the C-N group (1.00 ± 0.19), a significant 
difference was found between the two groups (P < 0.05). 
When comparing the C-N group with the C-G3 group, a sig-
nificantly higher relative expression of GATA-3 protein was 
found in the C-G3 group (4.10 ± 0.51, P < 0.05). Additionally, 
there no statistical difference found between the C-NC and 
C-LC groups or between the E-NC and E-LC groups.
Effect of GATA-3 on cell proliferation
As shown in Figure 2A and 2B, the relative cell prolif-
eration rate of each group obviously increased with time 
from 48 to 96 h. For intra-group comparison, the relative 
cell proliferation rates in the C-G3 group at 48, 72 and 96 h 
were 1.59 ± 0.05, 2.02 ± 0.01 and 2.59 ± 0.05, respectively, 
which were significantly higher than that in the C-N, C-NC 
and C-LC groups (P < 0.05, Tab. 2 and Fig. 2A). There was 
no significant difference between the C-N, C-NC and C-LC 
groups at 48, 72 or 96 h. In the experimental group, the 
relative cell proliferation rate in the E-siG3 group at 48 h was 
1.45 ± 0.05, which was significantly lower than that in the 
E-N (2.02 ± 0.06), E-NC (1.97 ± 0.04) and E-LC (2.01 ± 0.09) 
groups (P < 0.05, Tab. 2 and Fig. 2B). Similar comparative 
results were found at 72 and 96 h. No significant difference 
was found between the E-N, E-NC or E-LC groups. 
With regard to inter-group comparison, the relative cell 
proliferation rates in the E-N group at 48, 72 and 96 h were 
significantly higher than in the C-N group (P < 0.05, Tab. 2). 
DISCUSSION
Endometriosis is an inflammatory disease involving 
a possible shift towards the Th2-mediated immune response 
[13, 14]. As a Th2 cell-specific transcription factor, GATA-3 has 
been found to play important roles in cell proliferation and 
differentiation of the mammary glands [15], nephric duct 
[16] and nervous system [17]. In this study, GATA-3 was 
up-regulated in the primary endometrial cells of endo-
metriosis patients compared to controls. In addition, the 
Table 1. The mRNA and protein expressions of GATA-3 measured by 
real-time fluorescence quantitative polymerase chain reaction and 
western blot respectively
Groups
GATA-3 mRNA 
expression
GATA-3 protein 
expression
C-N 1.00 ± 0.10 1.00 ± 0.19
C-NC 1.17 ± 0.23 1.13 ± 0.38
C-LC 1.06 ± 0.18 1.13 ± 0.36
C-G3 4.64 ± 0.14 4.10 ± 0.51
E-N 2.30 ± 0.03 2.43 ± 0.12
E-NC 2.56 ± 0.58 2.49 ± 0.33
E-LC 2.44 ± 0.30 2.43 ± 0.40
E-siG3 0.62 ± 0.20 1.02 ± 0.14
C-G3 — control-GATA-3 lentiviral transfection; C-LC — control-lentiviral transfection 
control; C-N — control-no treatment; C-NC — control-negative control (transfected 
with negative control scrambled siRNA); E-LC — experiment-lentiviral transfection 
control; E-N — experiment-no treatment; E-NC — experiment-negative control; 
E-siG3 — experiment-siGATA-3 lentiviral transfection; GAPDH — glyceraldehyde-
3-phosphatedehydrogenase.
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proliferation rate of endometrial cells in the endometriosis 
group was significantly higher than in the control group. 
Importantly, after the endometrial cells of endometriosis pa-
tients were transfected with GATA-3 siRNA, the proliferation 
rate significantly decreased. However, in the control group, 
when the endometrial cells of were transfected with GATA-3, 
their proliferation rate increased significantly.
As mentioned above, cytokines play important roles in the 
immune and menstrual functions of the endometrium [18]. 
GATA-3 regulates the expression of cytokines in lymphocytes 
[8]. Some studies have demonstrated the role of GATA-3 in 
the endometrium throughout the menstrual cycle and in 
women with endometriosis [10, 19, 20]. Consistent with the 
findings above, this study revealed increased expressions of 
GATA-3 mRNA and protein in the primary endometrial cells 
of endometriosis patients compared to controls. Therefore, 
GATA-3 may be used as a biomarker in the diagnosis and 
treatment of patients with endometriosis.
Figure 2. The relative proliferation ability of endometriotic cells in (A) control group and (B) experimental group detected by Cell Counting Kit-8
Figure 1. The mRNA and protein expressions of GATA-3 were respectively measured by (A) real-time fluorescence quantitative polymerase chain 
reaction and (B) western blot. (C) The effect of GATA-3 gene silencing and overexpression in primary endometrial cells on GATA-3 protein expression 
were assayed by western blot. *P< 0.05
C-N — control-no treatment; C-NC — control-negative control (transfected with negative control scrambled siRNA); C-LC — control-lentiviral transfection 
control; C-G3 — control-GATA-3lentiviral transfection; C-LC — control-lentiviral transfection control; C-N — control-no treatment ; C-NC — control-
negative control (transfected with negative control scrambled siRNA); E-LC — experiment-lentiviral transfection control; E-N — experiment-no treatment; 
E-NC — experiment-negative control; E-siG3 — experiment-siGATA-3 lentiviral transfection; GAPDH — glyceraldehyde-3-phosphatedehydrogenase
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Table 2. The relative proliferation ability of endometriotic cells at 48 h, 72 h, and 96 h in control group and experimental group detected by 
Cell Counting Kit-8
Groups 48 h 72 h 96 h
C-N 1.00 ± 0.04 1.45 ± 0.19 1.96 ± 0.10
C-NC 1.08 ± 0.05 1.42 ± 0.16 1.93 ± 0.09
C-LC 1.02 ± 0.06 1.52 ± 0.03 1.94 ± 0.02
C-G3 1.59 ± 0.05 2.02 ± 0.01 2.59 ± 0.05
E-N 2.02 ± 0.06 2.30 ± 0.09 2.54 ± 0.04
E-NC 1.97 ± 0.04 2.24 ± 0.11 2.50 ± 0.15
E-LC 2.01 ± 0.09 2.31 ± 0.12 2.56 ± 0.03
E-siG3 1.45 ± 0.05 1.65 ± 0.06 1.92 ± 0.04
C-G3 — control-GATA-3 lentiviral transfection; C-LC — control-lentiviral transfection control; C-N — control-no treatment; C-NC — control-negative control (transfected 
with negative control scrambled siRNA); E-LC — experiment-lentiviral transfection control; E-N — experiment-no treatment; E-NC — experiment-negative control; 
E-siG3 — experiment-siGATA-3 lentiviral transfection
It has been suggested that immune mechanisms play 
an important role in endometriosis development. Studies 
have widely reported that a variety of abnormalities in im-
mune functions is related to this disease [21]. Specially, not 
only humoral immunity alterations, but also cell-mediated 
immunity have been reported in patients with endometrio-
sis [22]. Activated macrophages increase in endometriosis 
patients and secrete proinflammatory cytokines, such as 
interleukin-8 (IL-8) and IL-6 [23]. IL-8 promotes the growth 
and proliferation of endometrial cells [24]. Importantly, 
David [25] has reported that GATA-3 can promote the 
differentiation of Th2 cells and induces the expression 
of Th2 cytokines. Additionally, our previous study (un-
der publication) has suggested that GATA-3 can promote 
endometrial cells to secrete IL-8; therefore, we speculate 
that the role of GATA-3 in the proliferation of endometrial 
cells in patients with endometriosis may be associated 
with cytokine IL-8.
Furthermore, IL-4, another Th2 cytokine, has been 
linked to increased mRNA and protein expression in pe-
ripheral blood and peritoneal fluid of patients with endo-
metriosis [13, 26, 27]. The action of IL-4 in Th2 develop-
ment induces the early expression of GATA-3. In turn, the 
expression of Th2-specific cytokines including IL-4 can also 
be induced by GATA-3 with the contributions of other 
transcription factors [28]. Importantly, Zhuo et al. [29] 
demonstrated that IL-4 stimulated the proliferation of en-
dometriotic stromal cells. Taken together, we speculated 
that IL-4 may be another important cytokine implicated 
in the GATA-3-induced proliferation of endometrial cells 
in endometriosis patients.
CONCLUSIONS
Our results suggest the role of GATA-3 in promoting 
proliferation of endometrial cells. Additionally, we also 
found that blocking GATA-3 can reduce the proliferation of 
endometrial cells. GATA-3 may be used as a biomarker in the 
clinical diagnosis and treatment of endometriosis. Further 
studies are required to elucidate and confirm the exact 
mechanism.
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